Quentin Lesport
Research Subjects
Quentin Lesport has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Henry J. Kaminski
Department of Neurology and Rehabilitation Medicine, George Washington University, Washington, USA
6 shared publications - Marc Garbey
Department of Surgery, School of Medicine & Health Sciences, George Washington University, Washington, DC, United States
6 shared publications - Guillaume Joerger
Care Constitution Corp., Newark, DE 19702, USA
2 shared publications - Helen Girma
Department of Neurology & Rehabilitation Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA
2 shared publications - Mohammad Abu-Rub
Department of Neurology & Rehabilitation Medicine, School of Medicine & Health Sciences, George Washington University, Washington, DC, United States
2 shared publications - Sienna McNett
Department of Neurology & Rehabilitation Medicine, School of Medicine & Health Sciences, George Washington University, Washington, DC, United States
2 shared publications
Latest Publications
- Open Access
Feasibility study on a Noninvasive Assessment of ALS Patient Emotional State
This study addresses the need for objective, real-time assessment of emotional responsiveness and coping strategies in individuals with Amyotrophic Lateral Sclerosis (ALS) to support personalized care. We are using non-invasive speech analysis and data science methods on an expanded cohort comprising 28 ALS patient visits. We first demonstrate that commonly available artificial intelligence tools, including current-generation large language models (LLMs), such as ChatGPT, Gemini and Claude, do not provide reliable or reproducible assessments of patient concern levels in the absence of expert clinical supervision. Further, we observe a discrepancy between subjective and objective metrics such as the forced vital capacity for breathing. We introduce a novel functional classification system that contextualizes clinician-rated emotional concern relative to the patient’s functional impairment as measured by the ALS Functional Rating Scale (ALS-FRS). Patient responses are categorized as: Congruent: Emotional responsiveness is proportional to functional impairment. Muted: Emotional response is lower than expected given functional impairment. Excessive: Emotional response exceeds that expected given functional impairment Key Findings: Emotional Drivers and Acoustic Filtering We subsequently identified objective digital biomarkers, independent of LLMs, that robustly distinguish the muted and excessive response groups. Our data analysis revealed that the excessive response group was predominantly male and required significantly more clinician time, suggesting that this type of classification is primarily driven by psychosocial coping mechanisms such as anxiety related to functional dependency. Conversely, the muted response group was predominantly female. Most significantly, we discovered a direct link between this behavioral classification and the patient’s speech acoustics, demonstrating that dysarthria may act as an acoustic filter for emotional expression: Patients with muted response exhibited a voice profile characterized by high acoustic loudness, high sharpness, low roughness, and low fluctuation consistent with attenuation of emotional expression. Patients with excessive response presented with the opposing profile: low loudness, low sharpness, high roughness, and high fluctuation consistent with amplification of emotional expression. However, a significant diagnostic overlap exists between these biomarkers of anxiety and the early manifestations of Amyotrophic Lateral Sclerosis, spastic dysarthria for the former, flaccid dysarthria for the second. Our work enables non-invasive assessment of both emotional coping strategies and the dominant underlying neuromuscular mechanisms. These insights support the early identification of patients who may benefit from targeted, proactive interventions, and represent a significant step toward personalized ALS management.
Open AccessFeasibility study on a Noninvasive Assessment of ALS Patient Emotional State
This study addresses the need for objective, real-time assessment of emotional responsiveness and coping strategies in individuals with Amyotrophic Lateral Sclerosis (ALS) to support personalized care. We are using non-invasive speech analysis and data science methods on an expanded cohort comprising 28 ALS patient visits. We first demonstrate that commonly available artificial intelligence tools, including current-generation large language models (LLMs), such as ChatGPT, Gemini and Claude, do not provide reliable or reproducible assessments of patient concern levels in the absence of expert clinical supervision. Further, we observe a discrepancy between subjective and objective metrics such as the forced vital capacity for breathing. We introduce a novel functional classification system that contextualizes clinician-rated emotional concern relative to the patient’s functional impairment as measured by the ALS Functional Rating Scale (ALS-FRS). Patient responses are categorized as: Congruent: Emotional responsiveness is proportional to functional impairment. Muted: Emotional response is lower than expected given functional impairment. Excessive: Emotional response exceeds that expected given functional impairment Key Findings: Emotional Drivers and Acoustic Filtering We subsequently identified objective digital biomarkers, independent of LLMs, that robustly distinguish the muted and excessive response groups. Our data analysis revealed that the excessive response group was predominantly male and required significantly more clinician time, suggesting that this type of classification is primarily driven by psychosocial coping mechanisms such as anxiety related to functional dependency. Conversely, the muted response group was predominantly female. Most significantly, we discovered a direct link between this behavioral classification and the patient’s speech acoustics, demonstrating that dysarthria may act as an acoustic filter for emotional expression: Patients with muted response exhibited a voice profile characterized by high acoustic loudness, high sharpness, low roughness, and low fluctuation consistent with attenuation of emotional expression. Patients with excessive response presented with the opposing profile: low loudness, low sharpness, high roughness, and high fluctuation consistent with amplification of emotional expression. However, a significant diagnostic overlap exists between these biomarkers of anxiety and the early manifestations of Amyotrophic Lateral Sclerosis, spastic dysarthria for the former, flaccid dysarthria for the second. Our work enables non-invasive assessment of both emotional coping strategies and the dominant underlying neuromuscular mechanisms. These insights support the early identification of patients who may benefit from targeted, proactive interventions, and represent a significant step toward personalized ALS management.
- Open Access
- 28 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2920
Bridging the Heterogeneity of Myasthenia Gravis Scores as a Foundational Step Towards the Construction of a Digital Twin
Background/Objectives: Myasthenia gravis (MG) is a rare autoimmune neuromuscular disease. Clinical trials with rigorously collected data provide valuable opportunities for mathematical modeling of patient outcomes over time. However, for rare diseases such as MG, combining data across multiple trials presents challenges due to heterogeneity in outcome measures. This study aims to address these challenges by investigating relationships among commonly used MG outcome measures to support the development of a standardized “Myasthenia Gravis Portrait.” Methods: We integrated three primary data types from multiple clinical studies: (i) laboratory and medication data, (ii) Electronic Health Record (EHR) data (e.g., age, sex, years since diagnosis, BMI), and (iii) disease severity scores. We examined the relationships among several MG-specific scoring systems, including Activities of Daily Living (MG-ADL), Quantitative Myasthenia Gravis (QMG), MG Composite (MG-CE), and MG Quality of Life-15 (MGQOL-15), to evaluate consistency and comparability across studies. Results: Preliminary analyses revealed variable correlations among the different scoring systems, indicating that, while some measures capture overlapping aspects of disease progression, others reflect distinct patient- or clinician-centered perspectives. These findings highlight the need for a harmonized framework that captures both functional and clinical dimensions of MG severity. Conclusions: The proposed “Myasthenia Gravis Portrait” provides a standardized approach for representing patient outcomes across diverse clinical datasets. This framework will facilitate the creation of virtual populations of digital twins, enabling a machine-learning-based modeling of MG progression and prediction of individualized disease trajectories.
- 28 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2920
Open AccessBridging the Heterogeneity of Myasthenia Gravis Scores as a Foundational Step Towards the Construction of a Digital Twin
Background/Objectives: Myasthenia gravis (MG) is a rare autoimmune neuromuscular disease. Clinical trials with rigorously collected data provide valuable opportunities for mathematical modeling of patient outcomes over time. However, for rare diseases such as MG, combining data across multiple trials presents challenges due to heterogeneity in outcome measures. This study aims to address these challenges by investigating relationships among commonly used MG outcome measures to support the development of a standardized “Myasthenia Gravis Portrait.” Methods: We integrated three primary data types from multiple clinical studies: (i) laboratory and medication data, (ii) Electronic Health Record (EHR) data (e.g., age, sex, years since diagnosis, BMI), and (iii) disease severity scores. We examined the relationships among several MG-specific scoring systems, including Activities of Daily Living (MG-ADL), Quantitative Myasthenia Gravis (QMG), MG Composite (MG-CE), and MG Quality of Life-15 (MGQOL-15), to evaluate consistency and comparability across studies. Results: Preliminary analyses revealed variable correlations among the different scoring systems, indicating that, while some measures capture overlapping aspects of disease progression, others reflect distinct patient- or clinician-centered perspectives. These findings highlight the need for a harmonized framework that captures both functional and clinical dimensions of MG severity. Conclusions: The proposed “Myasthenia Gravis Portrait” provides a standardized approach for representing patient outcomes across diverse clinical datasets. This framework will facilitate the creation of virtual populations of digital twins, enabling a machine-learning-based modeling of MG progression and prediction of individualized disease trajectories.
- Open Access
Construction of patient trajectories to model clinical trial outcomes: Application to Myasthenia Gravis
Accurate prediction of patient outcomes in clinical trials is crucial for timely assessment of treatment efficacy. This study introduces a novel approach to predict patient response by constructing temporal trajectories from longitudinal clinical data. We aim to extrapolate these trajectories to forecast individual outcomes and identify when new patients align with established response patterns. Utilizing data from the MGTX trial of myasthenia gravis patients, we evaluate the predictability of these trajectories and discuss potential confounding factors. Furthermore, our analysis yields an automatic clustering of patients based on treatment success, revealing potential associations with age and smoking status.
Open AccessConstruction of patient trajectories to model clinical trial outcomes: Application to Myasthenia Gravis
Accurate prediction of patient outcomes in clinical trials is crucial for timely assessment of treatment efficacy. This study introduces a novel approach to predict patient response by constructing temporal trajectories from longitudinal clinical data. We aim to extrapolate these trajectories to forecast individual outcomes and identify when new patients align with established response patterns. Utilizing data from the MGTX trial of myasthenia gravis patients, we evaluate the predictability of these trajectories and discuss potential confounding factors. Furthermore, our analysis yields an automatic clustering of patients based on treatment success, revealing potential associations with age and smoking status.
- Open Access
Improving Care for Amyotrophic Lateral Sclerosis with Artificial Intelligence and Affective Computing
Background: Patients with ALS often face difficulties expressing emotions due to impairments in facial expression, speech, body language, and cognitive function. This study aimed to develop non-invasive AI tools to detect and quantify emotional responsiveness in ALS patients, providing objective insights. Improved understanding of emotional responses could enhance patient-provider communication, telemedicine effectiveness, and clinical trial outcome measures. Methods: In this pilot study, fourteen patients with ALS had audio recordings performed during routine clinic visits while wearing a wireless pulse oximeter. Emotion-triggering questions related to symptom progression, breathing, mobility, feeding tube, and financial burden were randomly asked. The same questions were posed in separate psychiatric evaluations. Natural language processing (NLP) was used to analyze transcriptions, topic classifications, sentiment, and emotional states, combining pulse and speech data. AI-generated reports summarized the findings. Results: Pulse alterations consistent with emotional arousal were identified, with longer consultations and positive communication reducing pulse fluctuations. Financial concerns triggered the strongest emotional response, while discussions about breathing, mobility, and feeding tube increased anxiety. AI-generated reports prioritized patient concerns and streamlined documentation for providers. Conclusions: This study introduces a novel approach to linking pulse and speech analysis to evaluate emotional responses in ALS patients. AI and affective computing provide valuable insights into emotional states and disease progression, with potential applications for other neurological disorders. This approach could augment clinical trial outcomes by offering a more comprehensive view of patient well-being.
Open AccessImproving Care for Amyotrophic Lateral Sclerosis with Artificial Intelligence and Affective Computing
Background: Patients with ALS often face difficulties expressing emotions due to impairments in facial expression, speech, body language, and cognitive function. This study aimed to develop non-invasive AI tools to detect and quantify emotional responsiveness in ALS patients, providing objective insights. Improved understanding of emotional responses could enhance patient-provider communication, telemedicine effectiveness, and clinical trial outcome measures. Methods: In this pilot study, fourteen patients with ALS had audio recordings performed during routine clinic visits while wearing a wireless pulse oximeter. Emotion-triggering questions related to symptom progression, breathing, mobility, feeding tube, and financial burden were randomly asked. The same questions were posed in separate psychiatric evaluations. Natural language processing (NLP) was used to analyze transcriptions, topic classifications, sentiment, and emotional states, combining pulse and speech data. AI-generated reports summarized the findings. Results: Pulse alterations consistent with emotional arousal were identified, with longer consultations and positive communication reducing pulse fluctuations. Financial concerns triggered the strongest emotional response, while discussions about breathing, mobility, and feeding tube increased anxiety. AI-generated reports prioritized patient concerns and streamlined documentation for providers. Conclusions: This study introduces a novel approach to linking pulse and speech analysis to evaluate emotional responses in ALS patients. AI and affective computing provide valuable insights into emotional states and disease progression, with potential applications for other neurological disorders. This approach could augment clinical trial outcomes by offering a more comprehensive view of patient well-being.
- Open Access
Application of Digital Tools and Artificial Intelligence to the Myasthenia Gravis Core Examination
Background Advances in video image analysis and artificial intelligence provide the opportunity to transform the approach to patient evaluation through objective digital evaluation. Objectives We assessed ability to quantitate Zoom video recordings of a standardized neurological examination the myasthenia gravis core examination (MG-CE), which had been designed for telemedicine evaluations. Methods We used Zoom (Zoom Video Communications) videos of patients with myasthenia gravis undergoing the MG-CE. Computer vision in combination with artificial intelligence methods were used to build algorithms to analyze videos with a focus on eye or body motions. For the assessment of examinations involving vocalization, signal processing methods were developed, including natural language processing. A series of algorithms were built that could automatically compute the metrics of the MG-CE. Results Fifty-one patients with MG with videos recorded twice on separate days and 15 control subjects were assessed once. We were successful in quantitating lid, eye, and arm positions and as well as well as develop respiratory metrics using breath counts. Cheek puff exercise was found to be of limited value for quantitation. Technical limitations included variations in illumination, bandwidth, and recording being done on the examiner side, not the patient. Conclusions Several aspects of the MG-CE can be quantitated to produce continuous measures via standard Zoom video recordings. Further development of the technology offer the ability for trained, non-physician, health care providers to perform precise examination of patients with MG outside the clinic, including for clinical trials. Plain Language Summary Advances in video image analysis and artificial intelligence provide the opportunity to transform the approach to patient evaluation. Here, we asked whether video recordings of the typical telemedicine examination for the patient with myasthenia gravis be used to quantitate examination findings? Despite recordings not made for purpose, we were able to develop and apply computer vision and artificial intelligence to Zoom recorded videos to successfully quantitate eye muscle, facial muscle, and limb fatigue. The analysis also pointed out limitations of human assessments of bulbar and respiratory assessments. The neuromuscular examination can be enhanced by advance technologies, which have the promise to improve clinical trial outcome measures as well as standard care.
Open AccessApplication of Digital Tools and Artificial Intelligence to the Myasthenia Gravis Core Examination
Background Advances in video image analysis and artificial intelligence provide the opportunity to transform the approach to patient evaluation through objective digital evaluation. Objectives We assessed ability to quantitate Zoom video recordings of a standardized neurological examination the myasthenia gravis core examination (MG-CE), which had been designed for telemedicine evaluations. Methods We used Zoom (Zoom Video Communications) videos of patients with myasthenia gravis undergoing the MG-CE. Computer vision in combination with artificial intelligence methods were used to build algorithms to analyze videos with a focus on eye or body motions. For the assessment of examinations involving vocalization, signal processing methods were developed, including natural language processing. A series of algorithms were built that could automatically compute the metrics of the MG-CE. Results Fifty-one patients with MG with videos recorded twice on separate days and 15 control subjects were assessed once. We were successful in quantitating lid, eye, and arm positions and as well as well as develop respiratory metrics using breath counts. Cheek puff exercise was found to be of limited value for quantitation. Technical limitations included variations in illumination, bandwidth, and recording being done on the examiner side, not the patient. Conclusions Several aspects of the MG-CE can be quantitated to produce continuous measures via standard Zoom video recordings. Further development of the technology offer the ability for trained, non-physician, health care providers to perform precise examination of patients with MG outside the clinic, including for clinical trials. Plain Language Summary Advances in video image analysis and artificial intelligence provide the opportunity to transform the approach to patient evaluation. Here, we asked whether video recordings of the typical telemedicine examination for the patient with myasthenia gravis be used to quantitate examination findings? Despite recordings not made for purpose, we were able to develop and apply computer vision and artificial intelligence to Zoom recorded videos to successfully quantitate eye muscle, facial muscle, and limb fatigue. The analysis also pointed out limitations of human assessments of bulbar and respiratory assessments. The neuromuscular examination can be enhanced by advance technologies, which have the promise to improve clinical trial outcome measures as well as standard care.
- Open Access
- 19 April 2023
- Published by JMIR Publications Inc. in JMIR Neurotechnology
- Vol. 2 (1) , e43387
A Digital Telehealth System to Compute Myasthenia Gravis Core Examination Metrics: Exploratory Cohort Study
Background: Telemedicine practice for neurological diseases has grown significantly during the COVID-19 pandemic. Telemedicine offers an opportunity to assess digitalization of examinations and enhances access to modern computer vision and artificial intelligence processing to annotate and quantify examinations in a consistent and reproducible manner. The Myasthenia Gravis Core Examination (MG-CE) has been recommended for the telemedicine evaluation of patients with myasthenia gravis. Objective: We aimed to assess the ability to take accurate and robust measurements during the examination, which would allow improvement in workflow efficiency by making the data acquisition and analytics fully automatic and thereby limit the potential for observation bias. Methods: We used Zoom (Zoom Video Communications) videos of patients with myasthenia gravis undergoing the MG-CE. The core examination tests required 2 broad categories of processing. First, computer vision algorithms were used to analyze videos with a focus on eye or body motions. Second, for the assessment of examinations involving vocalization, a different category of signal processing methods was required. In this way, we provide an algorithm toolbox to assist clinicians with the MG-CE. We used a data set of 6 patients recorded during 2 sessions. Results: Digitalization and control of quality of the core examination are advantageous and let the medical examiner concentrate on the patient instead of managing the logistics of the test. This approach showed the possibility of standardized data acquisition during telehealth sessions and provided real-time feedback on the quality of the metrics the medical doctor is assessing. Overall, our new telehealth platform showed submillimeter accuracy for ptosis and eye motion. In addition, the method showed good results in monitoring muscle weakness, demonstrating that continuous analysis is likely superior to pre-exercise and postexercise subjective assessment. Conclusions: We demonstrated the ability to objectively quantitate the MG-CE. Our results indicate that the MG-CE should be revisited to consider some of the new metrics that our algorithm identified. We provide a proof of concept involving the MG-CE, but the method and tools developed can be applied to many neurological disorders and have great potential to improve clinical care.
- 19 April 2023
- Published by JMIR Publications Inc. in JMIR Neurotechnology
- Vol. 2 (1) , e43387
Open AccessA Digital Telehealth System to Compute Myasthenia Gravis Core Examination Metrics: Exploratory Cohort Study
Background: Telemedicine practice for neurological diseases has grown significantly during the COVID-19 pandemic. Telemedicine offers an opportunity to assess digitalization of examinations and enhances access to modern computer vision and artificial intelligence processing to annotate and quantify examinations in a consistent and reproducible manner. The Myasthenia Gravis Core Examination (MG-CE) has been recommended for the telemedicine evaluation of patients with myasthenia gravis. Objective: We aimed to assess the ability to take accurate and robust measurements during the examination, which would allow improvement in workflow efficiency by making the data acquisition and analytics fully automatic and thereby limit the potential for observation bias. Methods: We used Zoom (Zoom Video Communications) videos of patients with myasthenia gravis undergoing the MG-CE. The core examination tests required 2 broad categories of processing. First, computer vision algorithms were used to analyze videos with a focus on eye or body motions. Second, for the assessment of examinations involving vocalization, a different category of signal processing methods was required. In this way, we provide an algorithm toolbox to assist clinicians with the MG-CE. We used a data set of 6 patients recorded during 2 sessions. Results: Digitalization and control of quality of the core examination are advantageous and let the medical examiner concentrate on the patient instead of managing the logistics of the test. This approach showed the possibility of standardized data acquisition during telehealth sessions and provided real-time feedback on the quality of the metrics the medical doctor is assessing. Overall, our new telehealth platform showed submillimeter accuracy for ptosis and eye motion. In addition, the method showed good results in monitoring muscle weakness, demonstrating that continuous analysis is likely superior to pre-exercise and postexercise subjective assessment. Conclusions: We demonstrated the ability to objectively quantitate the MG-CE. Our results indicate that the MG-CE should be revisited to consider some of the new metrics that our algorithm identified. We provide a proof of concept involving the MG-CE, but the method and tools developed can be applied to many neurological disorders and have great potential to improve clinical care.
- Open Access
- 12 October 2022
- Published by JMIR Publications Inc. in JMIR Preprints
A Digital Telehealth System to Compute Myasthenia Gravis Core Examination Metrics: Exploratory Cohort Study (Preprint)
BACKGROUND Telemedicine practice for neurological diseases has grown significantly during the COVID-19 pandemic. Telemedicine offers an opportunity to assess digitalization of examinations and enhances access to modern computer vision and artificial intelligence processing to annotate and quantify examinations in a consistent and reproducible manner. The Myasthenia Gravis Core Examination (MG-CE) has been recommended for the telemedicine evaluation of patients with myasthenia gravis. OBJECTIVE We aimed to assess the ability to take accurate and robust measurements during the examination, which would allow improvement in workflow efficiency by making the data acquisition and analytics fully automatic and thereby limit the potential for observation bias. METHODS We used Zoom (Zoom Video Communications) videos of patients with myasthenia gravis undergoing the MG-CE. The core examination tests required 2 broad categories of processing. First, computer vision algorithms were used to analyze videos with a focus on eye or body motions. Second, for the assessment of examinations involving vocalization, a different category of signal processing methods was required. In this way, we provide an algorithm toolbox to assist clinicians with the MG-CE. We used a data set of 6 patients recorded during 2 sessions. RESULTS Digitalization and control of quality of the core examination are advantageous and let the medical examiner concentrate on the patient instead of managing the logistics of the test. This approach showed the possibility of standardized data acquisition during telehealth sessions and provided real-time feedback on the quality of the metrics the medical doctor is assessing. Overall, our new telehealth platform showed submillimeter accuracy for ptosis and eye motion. In addition, the method showed good results in monitoring muscle weakness, demonstrating that continuous analysis is likely superior to pre-exercise and postexercise subjective assessment. CONCLUSIONS We demonstrated the ability to objectively quantitate the MG-CE. Our results indicate that the MG-CE should be revisited to consider some of the new metrics that our algorithm identified. We provide a proof of concept involving the MG-CE, but the method and tools developed can be applied to many neurological disorders and have great potential to improve clinical care.
- 12 October 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Digital Telehealth System to Compute Myasthenia Gravis Core Examination Metrics: Exploratory Cohort Study (Preprint)
BACKGROUND Telemedicine practice for neurological diseases has grown significantly during the COVID-19 pandemic. Telemedicine offers an opportunity to assess digitalization of examinations and enhances access to modern computer vision and artificial intelligence processing to annotate and quantify examinations in a consistent and reproducible manner. The Myasthenia Gravis Core Examination (MG-CE) has been recommended for the telemedicine evaluation of patients with myasthenia gravis. OBJECTIVE We aimed to assess the ability to take accurate and robust measurements during the examination, which would allow improvement in workflow efficiency by making the data acquisition and analytics fully automatic and thereby limit the potential for observation bias. METHODS We used Zoom (Zoom Video Communications) videos of patients with myasthenia gravis undergoing the MG-CE. The core examination tests required 2 broad categories of processing. First, computer vision algorithms were used to analyze videos with a focus on eye or body motions. Second, for the assessment of examinations involving vocalization, a different category of signal processing methods was required. In this way, we provide an algorithm toolbox to assist clinicians with the MG-CE. We used a data set of 6 patients recorded during 2 sessions. RESULTS Digitalization and control of quality of the core examination are advantageous and let the medical examiner concentrate on the patient instead of managing the logistics of the test. This approach showed the possibility of standardized data acquisition during telehealth sessions and provided real-time feedback on the quality of the metrics the medical doctor is assessing. Overall, our new telehealth platform showed submillimeter accuracy for ptosis and eye motion. In addition, the method showed good results in monitoring muscle weakness, demonstrating that continuous analysis is likely superior to pre-exercise and postexercise subjective assessment. CONCLUSIONS We demonstrated the ability to objectively quantitate the MG-CE. Our results indicate that the MG-CE should be revisited to consider some of the new metrics that our algorithm identified. We provide a proof of concept involving the MG-CE, but the method and tools developed can be applied to many neurological disorders and have great potential to improve clinical care.